BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care

References

1. 1.↵
   United States Preventative Services Task Force. Risk Assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement. JAMA 2019;322:652–65.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Gorodetska I,
   2. Kozeretska I,
   3. Dubrovska A

   . BRCA genes: the role in genome stability, cancer stemness and therapy resistance. J Cancer 2019;10:2109–27.

   OpenUrl
3. 3.↵
   Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 2000;83:1301–8.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Miki Y,
   2. Swensen J,
   3. Shattuck-Eidens D,
   4. et al

   . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Norquist BM,
   2. Garcia RL,
   3. Allison KH,
   4. et al

   . The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer 2010;116:5261–71.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   Department of Health and Human Services Office of Disease Prevention and Health Promotion. Healthy People 2020: Genomics. 2019. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/genomics/objectives. Accessed October 4, 2019.
7. 7.↵
   1. Neff RT,
   2. Senter L,
   3. Salani R

   . BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Ther Adv Med Oncol 2017;9:519–31.

   OpenUrlPubMed
8. 8.↵
   1. Valencia OM,
   2. Samuel SE,
   3. Viscusi RK,
   4. et al

   . The role of genetic testing in patients with breast cancer: a review. JAMA Surg 2017;152:589–94.

   OpenUrl
9. 9.↵
   1. Bellcross CA,
   2. Leadbetter S,
   3. Alford SH,
   4. et al

   . Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral. Cancer Epidemiol Biomarkers Prev 2013;22:728–35.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Quillin JM,
    2. Krist AH,
    3. Gyure M,
    4. et al

    . Patient-reported hereditary breast and ovarian cancer in a primary care practice. J Commun Genet 2014;5:179–83.

    OpenUrl
11. 11.↵
    1. Hull LE,
    2. Haas JS,
    3. Simon SR

    . Provider discussions of genetic tests with U.S. women at risk for a BRCA mutation. Am J Prev Med 2018;54:221–8.

    OpenUrl
12. 12.↵
    1. Malone KE,
    2. Daling JR,
    3. Doody DR,
    4. et al

    . Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 2006;66:8297–308.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Ashton-Prolla P,
    2. Giacomazzi J,
    3. Schmidt AV,
    4. et al

    . Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care. BMC Cancer 2009;9:283.

    OpenUrlCrossRefPubMed
14. 14.↵
    U.S. Census Bureau. 2019. QuickFacts: United States. Available from: https://www.census.gov/quickfacts/fact/table/US/PST045218. Accessed October 4, 2019.
15. 15.↵
    U.S. Census Bureau. 2018. Historical marital status tables. Available from: https://www.census.gov/data/tables/time-series/demo/families/marital.html. Accessed October 4, 2019.
16. 16.↵
    US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355–61.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Gilpin C,
    2. Carson N,
    3. Hunter A

    . A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 2000;58:299–308.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Antoniou AC,
    2. Hardy R,
    3. Walker L,
    4. et al

    . Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 2008;45:425–31.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Teller P,
    2. Hoskins KF,
    3. Zwaagstra A,
    4. et al

    . Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol 2010;17:240–6.

    OpenUrlCrossRefPubMed
20. 20.↵
    U.S. Census Bureau. National Population by Characteristics: 2010-2019. Available from: https://www.census.gov/data/tables/time-series/demo/popest/2010s-national-detail.html. Accessed March 25, 2020.
21. 21.↵
    Bureau of Labor Statistics. Occupational Employment and Wages, May 2018: 29-9092 Genetic Counselors. Available from: https://www.bls.gov/oes/2018/may/oes299092.htm. Accessed March 25, 2020.
22. 22.↵
    1. Peto J,
    2. Collins N,
    3. Barfoot R,
    4. et al

    . Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999;91:943–9.

    OpenUrlCrossRefPubMedWeb of Science